Acadian Asset Management
RCUS icon

Acadian Asset Management’s Arcus Biosciences RCUS Stock Holding History

Acadian Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93K Buy
+4,350
New +$93.9K ﹤0.01% 1767
2025
Q4 		– Sell
-32,358
Closed -$438K – 2094
2025
Q3 		$438K Buy
+32,358
New +$336K ﹤0.01% 1255
2025
Q2 		– Sell
-22,932
Closed -$180K – 1804
2025
Q1 		$180K Sell
22,932
-7,871
-26% -$91.3K ﹤0.01% 1274
2024
Q4 		$458K Buy
30,803
+29,507
+2,277% +$482K ﹤0.01% 1094
2024
Q3 		$19K Buy
+1,296
New +$20.4K ﹤0.01% 1983
2023
Q2 		– Sell
-1,444
Closed -$26K – 1878
2023
Q1 		$26K Hold
1,444
– – ﹤0.01% 1623
2022
Q4 		$29K Buy
+1,444
New +$39.7K ﹤0.01% 1660
2021
Q3 		– Sell
-5,022
Closed -$137K – 1964
2021
Q2 		$137K Sell
5,022
-3,576
-42% -$102K ﹤0.01% 1549
2021
Q1 		$241K Buy
8,598
+5,938
+223% +$207K ﹤0.01% 1437
2020
Q4 		$69K Buy
+2,660
New +$64.4K ﹤0.01% 1859
2020
Q3 		– Sell
-954
Closed -$24K – 2321
2020
Q2 		$24K Sell
954
-2,079
-69% -$56.1K ﹤0.01% 2102
2020
Q1 		$42K Buy
+3,033
New +$37.7K ﹤0.01% 1539
2019
Q4 		– Sell
-7,708
Closed -$70K – 2028
2019
Q3 		$70K Buy
+7,708
New +$61.9K ﹤0.01% 1562

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Acadian Asset Management's RCUS Position: Q1 2026 in Review

Acadian Asset Management opened a new position in Arcus Biosciences (RCUS) in Q1 2026: 4,350 shares worth $93K. The stake represents ﹤0.01% of the portfolio and ranks #1767 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in RCUS as recently as Q3 2025.

Acadian Asset Management first reported a position in RCUS in Q3 2019 and has held it in 13 quarters since. The position peaked at $458K in Q4 2024. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Acadian Asset Management held 4,350 shares of Arcus Biosciences worth $93K as of Q1 2026.
  • Arcus Biosciences was a new Acadian Asset Management position in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1767 holding.
  • Acadian Asset Management first reported a position in Arcus Biosciences in Q3 2019 and has held it in 13 quarters since.
  • Acadian Asset Management's Arcus Biosciences position peaked at $458K in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.